Pitt Shield

Displacement Imaging for Focused Ultrasound Peripheral Nerve Neuromodulation.

Authors: Lee SA, Kamimura HAS, Burgess MT, Konofagou EE

Focused ultrasound (FUS) is an emerging technique for neuromodulation due to its noninvasive application and high depth penetration. Recent studies have reported success in modulation of brain circuits, peripheral nerves, ion channels, and organ structures. In particular, neuromodulation of peripheral nerves and the underlying mechanisms remain comparatively unexplored in vivo. Lack of methodologies for FUS targeting and monitoring impede further research in in vivo studies. Thus, we developed a method that non-invasively measures nerve engagement, via tissue displacement, during FUS neuromodulation of in vivo nerves using simultaneous high frame-rate ultrasound imaging. Using this system, we can validate, in real-time, FUS targeting of the nerve and characterize subsequent compound muscle action potentials (CMAPs) elicited from sciatic nerve activation in mice using 0.5 to 5 ms pulse durations and 22 - 28 MPa peak positive stimulus pressures at 4 MHz. Interestingly, successful motor excitation from FUS neuromodulation required a minimum interframe nerve displacement of 18 μm without any displacement incurred at the skin or muscle levels. Moreover, CMAPs detected in mice monotonically increased with interframe nerve displacements within the range of 18 to 300 μm . Thus, correlation between nerve displacement and motor activation constitutes strong evidence FUS neuromodulation is driven by a mechanical effect given that tissue deflection is a result of highly focused acoustic radiation force.

Introduction

Purpose Transcranial ultrasound stimulation
Study Objective To develop and demonstrate a noninvasive, simultaneous high-frame-rate ultrasound imaging method to measure nerve engagement (via tissue displacement) and validate focused ultrasound neuromodulation in vivo by correlating displacement with motor activation.
Animal model / Human subject Mouse (Mus musculus); strain not specified; age not specified; sex not specified
Disease model Healthy
MRI or image guidance method High frame-rate ultrasound imaging

Outcomes and Safety

Summary of Outcomes FUS (4 MHz, 22–28 MPa peak positive pressure, 0.5–5 ms pulses) evoked sciatic nerve-driven CMAPs in mice when interframe nerve displacement reached ≥18 μm, with CMAP amplitude increasing monotonically for displacements from 18–300 μm; no displacement occurred in skin or muscle, supporting a mechanical (acoustic radiation force) mechanism.
Duration of biological effect 0.5 to 5 ms
Safety-related matter No adverse effects or safety issues are reported in the paper; the authors do not mention any observed harm from FUS neuromodulation in their in vivo mouse experiments.

Brain Region

Visualization unavailable

Ultrasound Parameters

FUS Frequency 4 MHz
FUS Pressure 22-28 MPa
FUS Mode pulsed
Pulse duration 0.5 to 5 ms
Focal Characteristics focal depth: None, focal length: None, aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search